EKSO BIONICS HOLDING (OTCBB:EKSO) has been moving up after it announced the acquisition of a third contract with US Special Operations Command. EKSO has been called in for the third development phase of the “Tactical Assault Light Operator Suit”, after successful completion of the second phase. Additionally, the company has been gaining patents for the technology being used in its projects with DARPA and the US government. The company has been gaining strength in terms of finances as well, but unfortunately fails to keep its stock on the rise.

It is important to note here that despite EKSO having had no promotion, since its listing on the OTCBB, it still trades millions of shares and is one of the top stocks in the market. Financially, the company has become very strong in the past year. EKSO’s medical devices are high in demand and contribute the most to its revenues. The company also has 12-patents from its operations with the US government alone.

As per the company’s 1Q2015, it experienced a revenue growth of 87% compared to the same period for the previous year, owing to the increased sales of medical devices. However, the cost of revenue increased by 142% for medical devices. Additional increases in marketing, R&D and administrative expenses led to the company reporting a net loss of $4.1 million, compared to $81.8 million for the same period in the preceding year.

Overall, the company has been making financial progress and its recent associations with the US military would definitely yield some good results. Additionally, EKSO is also concentrating on expanding its distribution network for medical devices. However, the company really needs to work on minimizing its operating expenses. As per its last filing, EKSO had $21.1 million in cash a decline from $25.2 million. $3.8 million was used by the company in operations, compared to $5.5 million in the preceding year.

EKSO BIONICS HOLDING (OTCBB:EKSO) closed at $1.84, the company traded 102.60 million shares on May 26 and lost 7.54% in share value.

Previous articleFederal National Mortgage Assctn Fnni Me (OTCBB:FNMA) Announces Another Dividend to the Treasury With No Sign of Being Released from Federal Control
Next articleAnavex Life Sciences Corp (OTCMKTS:AVXL) Reports Pre-Clinical Data for Potential Seizure Drug
Steve Kanaval: Portfolio Manager/Writer/ Market Analyst Steve began his career in the Trading Pits in Chicago making markets at the Chicago Mercantile Exchange (NYSE:CME) the Chicago Board of Trade and the CBOE in the early 80’s. He ran the Morgan Stanley Derivative Prop Trading for the firm specializing in Index Arbitrage. He continued his career as a Trader/Portfolio Manager for multiple Hedge Funds during the Internet Boom of the 90’s managing large portfolios. Steve is known as an expert in MicroCap Technology Stocks and the emerging Digital Currency markets as a Portfolio Manager for his Family Office. Steve has managed portfolio’s in volatile asset classes for 3 decades as a commodity trader, hedge fund manager and digital currency trader and miner. Steve publishes his views on the asset classes in a public forum and has published more than 10,000 articles simplifying these complex and volatile assets for readers. His work is published on multiple sites including Bloomberg,,, CryptoCurrencyNews as a paid contributor. His work includes research, journalism and archived video on important market volatility related to stocks, digital currency and other volatile misunderstood asset classes. He offers a humorous, unique insight and the related back stories and drivers for readers interested in volatility and emerging market assets. Full disclosure Steve is long 25 digital currencies and sits on the board of multiple public companies involved in digital currencies, and owns shares in these companies from time to time.